Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited at its 30th meeting of the fifth session of the board of directors held on 6 December 2013, passed the resolution in relation to the nomination of Ms. Liu Juyan, Mr. Ni Yidong, and Mr. Wang Wenchu as candidates for election as executive directors of the new session of the Board of the Company, and Mr. Fang Shuting and Mr. Chu Xiaoping as candidates for election as independent non-executive directors of the new session of the Board of the company. Ms. Liu Juyan started her career since July 1990 and served as chairman and general manager of Guangzhou Baiyunshan Han Fang Contemporary Pharmaceutical Co. Ltd. and director of technology and quality department of GPHL.

Ms. Liu has served as Chief Engineer of GPHL since May 2010 and as deputy general manager of GPHL since January 2011. She is also the member of the thirteenth session of the People's Congress of Guangzhou City, Outstanding City Management Experts of Guangzhou City and a Guangzhou 121 reserved talent. Ms. Liu has extensive experience in scientific research and development and technical research.

Mr. Ni Yidong started his career since July 1994 and served as the director of market planning department of GPHL and chairman of Guangzhou Baiyunshan Zhong Yi Pharmaceutical Co. Ltd. He is the deputy general manager and director of the grand health office of GPHL, secretary of the party committee of Zhong Yi and standing vice-chairman of WLJ Great Health Industry Co. Ltd. Mr. Wang Wenchu started his career since July 1988 and served as deputy factory manager of Guangzhou Baiyunshan Pharmaceutical General Factory and general manager of Baiyunshan.

He is currently the standing deputy factory manager of Guangzhou Baiyunshan Pharmaceutical General Factory, chairman of Guang Hua, chairman of Guangzhou Baiyunshan Pharmaceutical Technology Development Co. Ltd. and chairman of Guangzhou Baiyunshan Jing Xiu Tang Pharmaceutical Co. Ltd. Mr. Fang Shuting is currently the chairman of the China Association of Traditional Chinese Medicine and the independent director of Shandong Wohua Pharmaceutical Co.

Ltd. and China Traditional Chinese Medicine Co. Limited (listed on The Stock Exchange of Hong Kong Limited). Mr. Fanghas extensive experience in traditional Chinese medicine management and pharmaceutical industry.

Mr. Chu Xiaoping, He was an independent director of Guangdong Shengyi Technology Co. Ltd. for 6 years. He is currently a professor and a tutor of doctorate candidate of Lingnan College of Sun Yat-sen University.